A father, son, and friend in Northern California have agreed pay the SEC a combined $170,000 to settle charges that they engaged in insider trading around GE Healthcare’s $587 million acquisition of Clarient in 2010.
John McEnery III, his son John McEnery IV, and longtime friend Michael Rawitser did not admit or deny the allegations in the SEC’s complaint filed in federal court in San Jose, SEC said Wednesday. The settlement is still subject to court approval.
In a way, the case serves as a warning to anyone working at a medical device company acquisition target: be extremely careful whom you tell your good news to.
Help employers find you! Check out all the jobs and post your resume.
John McEnery III, his son John McEnery IV, and longtime friend Michael Rawitser did not admit or deny the allegations in the SEC’s complaint filed in federal court in San Jose, SEC said Wednesday. The settlement is still subject to court approval.
In a way, the case serves as a warning to anyone working at a medical device company acquisition target: be extremely careful whom you tell your good news to.
Help employers find you! Check out all the jobs and post your resume.
